Source:http://linkedlifedata.com/resource/pubmed/id/10637388
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-2-10
|
pubmed:abstractText |
Two hundred and two patients (97 female and 105 male; mean age: 45. 5+/-9 years) received CarboMedics bileaflet valves during a period of eight years. Ninety-one patients received mitral, 72 aortic and 39 aortic+mitral valve prosthesis. Tricuspid plasty and coronary artery bypass surgery were the concomitant operations in 17 and 12 patients, respectively. The mean follow-up period was 24.7 months and the ratio was 91%. Overall operative mortality was 3.96% (8 patients); 2.78% for aortic valve replacement (AVR), 3.29% for mitral valve replacement (MVR) and 7.7% for double valve replacement (DVR). The late mortality rate was 2.89% for AVR, 2.2% for MVR and 8. 3% for DVR. The main cause of mortality was low cardiac output. The overall survival rate was 91.5% in 2 years. The actuarial freedom from thromboembolism in 2 years was 97% for AVR, 95% for MVR and 84% for DVR. No mortality due to heamorrhagic events was observed. CarboMedics prosthetic heart valves may be used satisfactorily with a low incidence of valve-related morbidity and mortality.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1341-1098
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
382-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10637388-Actuarial Analysis,
pubmed-meshheading:10637388-Adolescent,
pubmed-meshheading:10637388-Adult,
pubmed-meshheading:10637388-Aged,
pubmed-meshheading:10637388-Analysis of Variance,
pubmed-meshheading:10637388-Aortic Valve,
pubmed-meshheading:10637388-Cardiac Output, Low,
pubmed-meshheading:10637388-Cause of Death,
pubmed-meshheading:10637388-Coronary Artery Bypass,
pubmed-meshheading:10637388-Female,
pubmed-meshheading:10637388-Follow-Up Studies,
pubmed-meshheading:10637388-Heart Valve Prosthesis,
pubmed-meshheading:10637388-Heart Valve Prosthesis Implantation,
pubmed-meshheading:10637388-Humans,
pubmed-meshheading:10637388-Incidence,
pubmed-meshheading:10637388-Male,
pubmed-meshheading:10637388-Middle Aged,
pubmed-meshheading:10637388-Mitral Valve,
pubmed-meshheading:10637388-Postoperative Hemorrhage,
pubmed-meshheading:10637388-Prosthesis Design,
pubmed-meshheading:10637388-Survival Rate,
pubmed-meshheading:10637388-Thromboembolism,
pubmed-meshheading:10637388-Tricuspid Valve
|
pubmed:year |
1999
|
pubmed:articleTitle |
Eight year experience with the CarboMedics bileaflet valvular prosthesis.
|
pubmed:affiliation |
Department of Thoracic and Cardiovascular Surgery, Gazi University School of Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|